131 related articles for article (PubMed ID: 3485470)
1. Prognostic indicators of colon tumors. The Gastrointestinal Tumor Study Group experience.
Steinberg SM; Barkin JS; Kaplan RS; Stablein DM
Cancer; 1986 May; 57(9):1866-70. PubMed ID: 3485470
[TBL] [Abstract][Full Text] [Related]
2. Obstruction and perforation in colorectal adenocarcinoma: an analysis of prognosis and current trends.
Chen HS; Sheen-Chen SM
Surgery; 2000 Apr; 127(4):370-6. PubMed ID: 10776426
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of tumor location and bowel obstruction in Dukes B and C colorectal cancer. Findings from the NSABP clinical trials.
Wolmark N; Wieand HS; Rockette HE; Fisher B; Glass A; Lawrence W; Lerner H; Cruz AB; Volk H; Shibata H
Ann Surg; 1983 Dec; 198(6):743-52. PubMed ID: 6357118
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in 2230 Korean colorectal cancer patients: analysis of consecutively operated cases.
Park YJ; Park KJ; Park JG; Lee KU; Choe KJ; Kim JP
World J Surg; 1999 Jul; 23(7):721-6. PubMed ID: 10390594
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04).
Mamounas E; Wieand S; Wolmark N; Bear HD; Atkins JN; Song K; Jones J; Rockette H
J Clin Oncol; 1999 May; 17(5):1349-55. PubMed ID: 10334518
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
Garrity MM; Burgart LJ; Mahoney MR; Windschitl HE; Salim M; Wiesenfeld M; Krook JE; Michalak JC; Goldberg RM; O'Connell MJ; Furth AF; Sargent DJ; Murphy LM; Hill E; Riehle DL; Meyers CH; Witzig TE;
J Clin Oncol; 2004 May; 22(9):1572-82. PubMed ID: 15117979
[TBL] [Abstract][Full Text] [Related]
7. Tumor ploidy as a risk factor for disease recurrence and short survival in surgically treated Dukes' B2 colon cancer patients.
Nori D; Merimsky O; Saw D; Cortes E; Chen E; Chassin J
Tumour Biol; 1996; 17(2):75-80. PubMed ID: 8658016
[TBL] [Abstract][Full Text] [Related]
8. Importance of tumor pathology and morphology in patients with surgically resected colon cancer. Findings from the Gastrointestinal Tumor Study Group.
Steinberg SM; Barwick KW; Stablein DM
Cancer; 1986 Sep; 58(6):1340-5. PubMed ID: 3742458
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study.
Allegra CJ; Paik S; Colangelo LH; Parr AL; Kirsch I; Kim G; Klein P; Johnston PG; Wolmark N; Wieand HS
J Clin Oncol; 2003 Jan; 21(2):241-50. PubMed ID: 12525515
[TBL] [Abstract][Full Text] [Related]
10. Carcinoma of the colon and rectum: the natural history reviewed in 1704 patients.
Eisenberg B; Decosse JJ; Harford F; Michalek J
Cancer; 1982 Mar; 49(6):1131-4. PubMed ID: 7059938
[TBL] [Abstract][Full Text] [Related]
11. Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience.
Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
Jpn J Clin Oncol; 2000 Jan; 30(1):12-6. PubMed ID: 10770562
[TBL] [Abstract][Full Text] [Related]
12. The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer.
Moertel CG; O'Fallon JR; Go VL; O'Connell MJ; Thynne GS
Cancer; 1986 Aug; 58(3):603-10. PubMed ID: 3731019
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for survival after curative resection of Dukes' B colonic cancer.
Saha AK; Smith KJ; Sue-Ling H; Sagar PM; Burke D; Finan PJ
Colorectal Dis; 2011 Dec; 13(12):1390-4. PubMed ID: 21073647
[TBL] [Abstract][Full Text] [Related]
14. Tumor ploidy as a risk factor for disease recurrence and short survival in surgically-treated Dukes' B2 colon cancer patients.
Nori D; Merimsky O; Samala E; Saw D; Cortes E; Chen E; Turner JW
J Surg Oncol; 1995 Aug; 59(4):239-42. PubMed ID: 7630171
[TBL] [Abstract][Full Text] [Related]
15. Outcome of colon cancer initially presenting as colon perforation and obstruction.
Chen TM; Huang YT; Wang GC
World J Surg Oncol; 2017 Aug; 15(1):164. PubMed ID: 28841901
[TBL] [Abstract][Full Text] [Related]
16. Correlation of clinical data, anatomical site and disease stage in colorectal cancer.
Saidi HS; Karuri D; Nyaim EO
East Afr Med J; 2008 Jun; 85(6):259-62. PubMed ID: 18817021
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of vascular invasion in colorectal cancer of Dukes' B class.
Khankhanian N; Mavligit GM; Russell WO; Schimek M
Cancer; 1977 Mar; 39(3):1195-200. PubMed ID: 912654
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer.
Wang Y; Jatkoe T; Zhang Y; Mutch MG; Talantov D; Jiang J; McLeod HL; Atkins D
J Clin Oncol; 2004 May; 22(9):1564-71. PubMed ID: 15051756
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of surgical perforation of the rectum during abdominoperineal resection for rectal carcinoma.
Ranbarger KR; Johnston WD; Chang JC
Am J Surg; 1982 Feb; 143(2):186-8. PubMed ID: 7058986
[TBL] [Abstract][Full Text] [Related]
20. Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer.
Petersen VC; Baxter KJ; Love SB; Shepherd NA
Gut; 2002 Jul; 51(1):65-9. PubMed ID: 12077094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
